Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parameters.

Figurski MJ, Pawiński T, Goldberg LR, DeNofrio D, Nawrocki A, Taylor DO, Lake KD, Chojnowski D, Shaw LM.

Ann Transplant. 2012 Jan-Mar;17(1):68-78.

PMID:
22466911
2.

Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.

Park JM, Lake KD, Cibrik DM.

Ther Drug Monit. 2008 Oct;30(5):591-6. doi: 10.1097/FTD.0b013e3181858169.

3.
4.

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group.

N Engl J Med. 2006 Nov 9;355(19):1967-77.

5.

Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients.

Park JM, Lake KD, Arenas JD, Fontana RJ.

Liver Transpl. 2006 Jan;12(1):112-6. Erratum in: Liver Transpl. 2006 Mar;12(3):494.

6.

Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients.

Lake KD, Aaronson KD, Gorman LE, Pagani FD, Koelling TM.

J Heart Lung Transplant. 2005 Aug;24(8):990-4.

PMID:
16102431
7.

Immunosuppressive drugs and novel strategies to prevent acute and chronic allograft rejection.

Lake KD.

Semin Respir Crit Care Med. 2001 Oct;22(5):559-80.

PMID:
16088702
8.

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation.

McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, Davison JM, Easterling T, Friedman JE, Hou S, Karlix J, Lake KD, Lindheimer M, Matas AJ, Moritz MJ, Riely CA, Ross LF, Scott JR, Wagoner LE, Wrenshall L, Adams PL, Bumgardner GL, Fine RN, Goral S, Krams SM, Martinez OM, Tolkoff-Rubin N, Pavlakis M, Scantlebury V; Women's Health Committee of the American Society of Transplantation.

Am J Transplant. 2005 Jul;5(7):1592-9. Review.

9.

Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.

Wu AH, Ballantyne CM, Short BC, Torre-Amione G, Young JB, Ventura HO, Eisen HJ, Radovancevic B, Rayburn BK, Lake KD, Yancy CW Jr, Taylor DO, Mehra MR, Kubo SH, Fishbein DP, Zhao XQ, O'Brien KD.

Am J Cardiol. 2005 Feb 1;95(3):367-72.

PMID:
15670546
10.
11.

New prophylactic treatment strategy for cytomegalovirus disease.

Lake KD.

Am J Health Syst Pharm. 2003 Dec 1;60(23 Suppl 8):S13-6. Review.

PMID:
14686230
12.

Safety and efficacy of atorvastatin in heart transplant recipients.

Patel DN, Pagani FD, Koelling TM, Dyke DB, Baliga RR, Cody RJ, Lake KD, Aaronson KD.

J Heart Lung Transplant. 2002 Feb;21(2):204-10.

PMID:
11834348
13.

Time to first graft loss as a risk factor for second renal allograft loss.

Arndorfer JA, Meier-Kriesche HU, Ojo AO, Gruber SA, Cibrik DM, Lake KD, Kaplan B, Leichtman AB.

Transplant Proc. 2001 Feb-Mar;33(1-2):1188-9. No abstract available.

PMID:
11267251
14.

A retrospective assessment of safety, efficacy, and pharmacoeconomics of generic azathioprine in heart-transplant recipients.

Haroldson JA, Somerville KT, Carlson S, Hanson J, Emery RW, Lake KD.

J Heart Lung Transplant. 2001 Mar;20(3):372-4.

PMID:
11257565
15.

Clinical pharmacy: looking 20 years back... looking 20 years forward.

Angaran DM, Bonal J, Eide G, Koda-Kimble MA, Lake KD, Leufkens HG.

Pharmacotherapy. 2000 Oct;20(10 Pt 2):235S-242S. No abstract available.

16.

Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia.

Haroldson JA, Kramer LE, Wolff DL, Lake KD.

Ann Pharmacother. 2000 Feb;34(2):183-7.

PMID:
10676827
17.

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41.

18.

Nefazodone and cyclosporine drug-drug interaction.

Wright DH, Lake KD, Bruhn PS, Emery RW Jr.

J Heart Lung Transplant. 1999 Sep;18(9):913-5.

PMID:
10528754
19.

Effect of short-term rifampin on stable cyclosporine concentrations.

Freitag VL, Skifton RD, Lake KD.

Ann Pharmacother. 1999 Jul-Aug;33(7-8):871-2. No abstract available.

PMID:
10466920
20.

Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice.

Christenson SD, Lake KD, Ooboshi H, Faraci FM, Davidson BL, Heistad DD.

Stroke. 1998 Jul;29(7):1411-5; discussion 1416.

PMID:
9660397
21.

Policies regarding the transplantation of hepatitis C-positive candidates and donor organs.

Lake KD, Smith CI, LaForest SK, Allen J, Pritzker MR, Emery RW.

J Heart Lung Transplant. 1997 Sep;16(9):917-21.

PMID:
9322141
22.

Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

Lake KD, Compton DR, Varga K, Martin BR, Kunos G.

J Pharmacol Exp Ther. 1997 Jun;281(3):1030-7.

PMID:
9190833
23.

Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats.

Lake KD, Martin BR, Kunos G, Varga K.

Hypertension. 1997 May;29(5):1204-10.

PMID:
9149688
24.

Outcomes of hepatitis C positive (HCV+) heart transplant recipients.

Lake KD, Smith CI, Milfred-La Forest SK, Pritzker MR, Emery RW.

Transplant Proc. 1997 Feb-Mar;29(1-2):581-2. No abstract available.

PMID:
9123138
25.

Mechanism of the hypotensive action of anandamide in anesthetized rats.

Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G.

Hypertension. 1996 Oct;28(4):682-6.

PMID:
8843898
26.

Considerations for using ketoconazole in solid organ transplant recipients receiving cyclosporine immunosuppression.

Chapman SA, Lake KD, Solbrack DF, Milfred SK, Marshall PS, Kamps MA.

J Transpl Coord. 1996 Sep;6(3):148-54. Review.

PMID:
9188374
27.

Azathioprine and allopurinol: the price of an avoidable drug interaction.

Kennedy DT, Hayney MS, Lake KD.

Ann Pharmacother. 1996 Sep;30(9):951-4.

PMID:
8876853
28.

Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry.

Ballantyne CM, Bourge RC, Domalik LJ, Eisen HJ, Fishbein DP, Kubo SH, Lake KD, Radovancevic B, Taylor DO, Ventura HO, Yancy CW Jr, Young JB.

Am J Cardiol. 1996 Sep 1;78(5):532-5. Review.

PMID:
8806337
29.

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves.

Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G.

Br J Pharmacol. 1996 Aug;118(8):2023-8.

30.

Important interactions of drugs with immunosuppressive agents used in transplant recipients.

Lake KD, Canafax DM.

J Antimicrob Chemother. 1995 Oct;36 Suppl B:11-22. Review.

PMID:
8601538
31.

Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: functional and autoradiographic studies.

Sharif NA, Nunes JL, Lake KD, McClelland DL, Corkins SF, Lakatos I, Rosenkranz RP, Whiting RL, Eglen RM.

Gen Pharmacol. 1995 Jul;26(4):727-35.

PMID:
7635247
32.

Changes in health-related quality of life and depression in heart transplant recipients.

Fisher DC, Lake KD, Reutzel TJ, Emery RW.

J Heart Lung Transplant. 1995 Mar-Apr;14(2):373-81.

PMID:
7779859
33.
34.

Fever induced by dobutamine infusion.

Chapman SA, Stephan T, Lake KD, Sonnesyn SW, Emery RW.

Am J Cardiol. 1994 Sep 1;74(5):517. No abstract available.

PMID:
8059743
35.

Practices of cardiothoracic transplant centers regarding hepatitis C-seropositive candidates and donors.

Milfred SK, Lake KD, Anderson DJ, Hayney MS, Love KR, Emery RW, Pritzker MR.

Transplantation. 1994 Feb 27;57(4):568-72.

PMID:
8116043
36.

Does ciprofloxacin interact with cyclosporine?

Hoey LL, Lake KD.

Ann Pharmacother. 1994 Jan;28(1):93-6. Review.

PMID:
8123970
37.

The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.

Lake KD, Reutzel TJ, Pritzker MR, Jorgensen CR, Emery RW.

J Heart Lung Transplant. 1993 Jul-Aug;12(4):580-90.

PMID:
8369320
38.

Over-the-counter medications in cardiac transplant recipients: guidelines for use.

Lake KD, Nolen JG, Slaker RA, Reutzel TJ, Milfred SK, Solbrack DF, Hoffman FM.

Ann Pharmacother. 1992 Dec;26(12):1566-75. Review.

PMID:
1362365
39.

The pharmacokinetics and pharmacodynamics of immunosuppressive agents.

Lake KD, Kilkenny JM.

Crit Care Nurs Clin North Am. 1992 Jun;4(2):205-21. Review.

PMID:
1599643
40.

Postmortem changes and pharmacokinetics: review of the literature and case report.

Shepherd MF, Lake KD, Kamps MA.

Ann Pharmacother. 1992 Apr;26(4):510-4.

PMID:
1533552
41.

Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.

Pritzker MR, Lake KD, Reutzel TJ, Hoffman FM, Jorgensen CR, Pederson W, Emery RW.

J Heart Lung Transplant. 1992 Mar-Apr;11(2 Pt 2):415-20.

PMID:
1571339
42.

OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.

Prieto M, Lake KD, Pritzker MR, Jorgensen CR, Arom KV, Love KR, Emery RW.

J Heart Lung Transplant. 1991 Nov-Dec;10(6):901-11.

PMID:
1661608
43.

Mechanical circulatory assistance after heart transplantation.

Emery RW, Eales F, Joyce LD, Von Rueden TJ, King RM, Jorgensen CR, Pritzker MR, Johnson KE, Lake KD, Arom KV.

Ann Thorac Surg. 1991 Jan;51(1):43-7.

PMID:
1985572
44.

Management of drug interactions with cyclosporine.

Lake KD.

Pharmacotherapy. 1991;11(5):110S-118S. Review.

PMID:
1745616
45.

Comment: vancomycin dosing methods.

Lake KD, Peterson CD.

DICP. 1989 Jul-Aug;23(7-8):618-9. No abstract available.

PMID:
2763590
46.

Ganciclovir pharmacokinetics during renal impairment.

Lake KD, Fletcher CV, Love KR, Brown DC, Joyce LD, Pritzker MR.

Antimicrob Agents Chemother. 1988 Dec;32(12):1899-900.

47.

Evaluation of a method for initiating vancomycin therapy: experience in 205 patients.

Lake KD, Peterson CD.

Pharmacotherapy. 1988;8(5):284-6.

PMID:
3252194
48.

Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime.

Peterson CD, Lake KD, Arom KV, Love KR.

Drug Intell Clin Pharm. 1987 Sep;21(9):728-32.

PMID:
3498617
49.

Immunizing the pregnant woman. Risks versus benefits.

Saballus MK, Lake KD, Wager GP.

Postgrad Med. 1987 Jun;81(8):103-8, 113.

PMID:
3588455
50.

Proceedings of a symposium on careers in clinical pharmacy. Perspectives of a young clinical practitioner.

Lake KD.

Am J Hosp Pharm. 1986 Nov;43(11):2754-6. No abstract available.

PMID:
3799609

Supplemental Content

Support Center